KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Neogenomics (NEO) over the last 16 years, with Q3 2025 value amounting to $128.4 million.

  • Neogenomics' Shares Outstanding (Weighted Average) rose 115.16% to $128.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.4 million, marking a year-over-year increase of 115.16%. This contributed to the annual value of $126.7 million for FY2024, which is 92.11% up from last year.
  • Neogenomics' Shares Outstanding (Weighted Average) amounted to $128.4 million in Q3 2025, which was up 115.16% from $127.9 million recorded in Q2 2025.
  • Neogenomics' 5-year Shares Outstanding (Weighted Average) high stood at $128.4 million for Q3 2025, and its period low was $116.2 million during Q1 2021.
  • In the last 5 years, Neogenomics' Shares Outstanding (Weighted Average) had a median value of $125.4 million in 2023 and averaged $124.5 million.
  • In the last 5 years, Neogenomics' Shares Outstanding (Weighted Average) skyrocketed by 1121.22% in 2021 and then soared by 83.68% in 2024.
  • Neogenomics' Shares Outstanding (Weighted Average) (Quarter) stood at $120.0 million in 2021, then increased by 3.55% to $124.2 million in 2022, then grew by 1.03% to $125.5 million in 2023, then grew by 0.92% to $126.7 million in 2024, then grew by 1.39% to $128.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $128.4 million for Q3 2025, versus $127.9 million for Q2 2025 and $127.4 million for Q1 2025.